Sichenzia Ross Ference Kesner LLP Advises PolarityTE, Inc. on Acquisition of Intellectual Property Related to Regenerative Medicine
Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented PolarityTE, Inc. (NASDAQ: COOL), a company which has developed and distributed software through online platforms and is also engaged in regenerative medicine, in its acquisition of intellectual property related to a novel regenerative medicine and tissue engineering platform developed by Dr. Denver Lough, the Company’s current Chief Executive Officer. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $10 Million Public Offering for Creative Realities, Inc. - November 19, 2018
- Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering - November 15, 2018
- Sichenzia Ross Ference LLP被美国新闻评为2019年“最佳律师名单” - November 13, 2018